Related Experiment Video
Updated: Mar 16, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Impaired vascular function contributes to exercise intolerance in chronic kidney disease
Amaryllis H Van Craenenbroeck1,2,3, Emeline M Van Craenenbroeck2,4, Katrijn Van Ackeren2
1Department of Nephrology, Antwerp University Hospital, Wilrijkstraat 10, 2650 Edegem, Belgium.
Arterial stiffness significantly impairs exercise capacity in chronic kidney disease (CKD) patients before dialysis. This vascular dysfunction is a key target for improving aerobic fitness in CKD.
Area of Science:
- Nephrology
- Cardiovascular Physiology
- Exercise Physiology
Background:
- Exercise intolerance is common in chronic kidney disease (CKD), impacting morbidity and mortality.
- Mechanisms of exercise intolerance in predialysis CKD are not well understood.
- Vascular dysfunction and related microRNAs (miRNAs) are investigated as potential contributors.
Purpose of the Study:
- To investigate the role of vascular dysfunction in exercise intolerance in predialysis CKD.
- To analyze vascular-related miRNAs as epigenetic regulators of exercise capacity.
Main Methods:
- Included 63 CKD patients (stages 1-5) and 18 controls.
- Assessed peak oxygen consumption (VO2peak), endothelial function (flow-mediated dilation, FMD), and arterial stiffness (pulse wave velocity, PWV).
- Quantified plasma miRNA levels (miR-21, miR-126, miR-146a, miR-150, miR-210) using RT-PCR.
Main Results:
- VO2peak was reduced in mild CKD and correlated with estimated glomerular filtration rate (eGFR).
- Both FMD and PWV correlated with eGFR.
- Arterial stiffness (PWV) was a strong independent determinant of VO2peak, even after adjusting for other factors.
Conclusions:
- Arterial stiffness contributes to reduced aerobic capacity in predialysis CKD, independent of other factors.
- Arterial stiffness is a potential therapeutic target for improving exercise capacity in CKD.
- Further research is needed to understand the link between specific miRNAs, renal function, and arterial stiffness.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Heart Failure Drugs: Diuretics
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury II: Pathophysiology

